Keith Hyland
Corporate Officer/Principal bei LABCORP HOLDINGS INC.
Profil
Keith Hyland is the founder of Medical Neurogenetics LLC.
He is currently working as the Department of Neurochemistry at Laboratory Corp.
of America Holdings.
Previously, he worked as the Laboratory Director at Institute of Metabolic Disease and as the Director-Neurochemistry at Horizon Molecular Medicine.
Dr. Hyland completed his undergraduate and doctorate degrees from Brunel University in 1976 and 1980 respectively.
Aktive Positionen von Keith Hyland
Unternehmen | Position | Beginn |
---|---|---|
LABCORP HOLDINGS INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Keith Hyland
Unternehmen | Position | Ende |
---|---|---|
Horizon Molecular Medicine | Corporate Officer/Principal | - |
Medical Neurogenetics LLC
Medical Neurogenetics LLC Medical/Nursing ServicesHealth Services Medical Neurogenetics LLC specializes in neurogenetic and complex biochemical testing. It offers a complete neurogenetic testing menu and provides NGS tests for various genetic and inherited neurological conditions affecting children and adults, including epilepsy, muscular dystrophy, Parkinson’s, Alzheimer’s, and cellular energetics defects. The company was founded in 2001 and is headquartered in Atlanta, GA. | Gründer | - |
Institute of Metabolic Disease | Corporate Officer/Principal | - |
Ausbildung von Keith Hyland
Brunel University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings Services to the Health IndustryHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
Medical Neurogenetics LLC
Medical Neurogenetics LLC Medical/Nursing ServicesHealth Services Medical Neurogenetics LLC specializes in neurogenetic and complex biochemical testing. It offers a complete neurogenetic testing menu and provides NGS tests for various genetic and inherited neurological conditions affecting children and adults, including epilepsy, muscular dystrophy, Parkinson’s, Alzheimer’s, and cellular energetics defects. The company was founded in 2001 and is headquartered in Atlanta, GA. | Health Services |
Institute of Metabolic Disease | |
Horizon Molecular Medicine |